BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 34137890)

  • 21. Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) method for the determination of cannabidiol (CBD), Δ
    Palazzoli F; Citti C; Licata M; Vilella A; Manca L; Zoli M; Vandelli MA; Forni F; Cannazza G
    J Pharm Biomed Anal; 2018 Feb; 150():25-32. PubMed ID: 29202305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.
    Milman G; Barnes AJ; Lowe RH; Huestis MA
    J Chromatogr A; 2010 Feb; 1217(9):1513-21. PubMed ID: 20083251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.
    Sholler DJ; Zamarripa CA; Spindle TR; Martin EL; Kuntz D; Vandrey R; Grabenauer M
    J Anal Toxicol; 2022 Oct; 46(8):882-890. PubMed ID: 35770374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
    Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
    J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry.
    Poklis JL; Thompson CC; Long KA; Lichtman AH; Poklis A
    J Anal Toxicol; 2010 Oct; 34(8):516-20. PubMed ID: 21258613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extraction FROM dried oral fluid spots (DOFS) and LC-MS/MS detection.
    Gorziza R; Cox J; Limberger RP; Arroyo-Mora LE
    J Cannabis Res; 2021 Jul; 3(1):30. PubMed ID: 34253256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of cannabinoids in cannabis products using liquid chromatography-ion trap mass spectrometry.
    Stolker AA; van Schoonhoven J; de Vries AJ; Bobeldijk-Pastorova I; Vaes WH; van den Berg R
    J Chromatogr A; 2004 Nov; 1058(1-2):143-51. PubMed ID: 15595662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Will tetrahydrocannabinol be formed from cannabidiol in gastric fluid? An in vivo experiment.
    Franz S; Herzog J; Skopp G; Musshoff F
    Int J Legal Med; 2023 Jan; 137(1):79-87. PubMed ID: 36190564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry.
    Cliburn KD; Huestis MA; Wagner JR; Kemp PM
    J Chromatogr A; 2021 Aug; 1652():462345. PubMed ID: 34198104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoids assessment in plasma and urine by high performance liquid chromatography-tandem mass spectrometry after molecularly imprinted polymer microsolid-phase extraction.
    Sánchez-González J; Salgueiro-Fernández R; Cabarcos P; Bermejo AM; Bermejo-Barrera P; Moreda-Piñeiro A
    Anal Bioanal Chem; 2017 Feb; 409(5):1207-1220. PubMed ID: 27815614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans.
    Nahler G; Grotenhermen F; Zuardi AW; Crippa JAS
    Cannabis Cannabinoid Res; 2017; 2(1):81-86. PubMed ID: 28861507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitive determination of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol and complementary cannabinoids in hair using alkaline digestion and mixed-mode solid phase extraction followed by liquid-chromatography-tandem mass spectrometry.
    Schaefer VD; Müller VV; Feltraco Lizot LL; Hahn RZ; Schneider A; Antunes MV; Linden R
    Forensic Sci Int; 2021 Nov; 328():111047. PubMed ID: 34649099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis Use Surveillance by Sweat Analysis.
    Gambelunghe C; Fucci N; Aroni K; Bacci M; Marcelli A; Rossi R
    Ther Drug Monit; 2016 Oct; 38(5):634-9. PubMed ID: 27465974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LC-MS/MS quantification of Δ8-THC, Δ9-THC, THCV ISOMERS and their main metabolites in human plasma.
    Sempio C; Jorge Campos-Palomino MS; Klawitter J; Amy Harrison MA; Peters EN; MacNair L; Haghdoost M; Bonn-Miller M; Babalonis S; Huestis MA; Christians U; Klawitter J
    J Anal Toxicol; 2024 Jun; ():. PubMed ID: 38836589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A validated method for the simultaneous quantification of cannabidiol, Δ
    Kevin RC; Vogel R; Doohan P; Berger M; Amminger GP; McGregor IS
    Drug Test Anal; 2021 Mar; 13(3):614-627. PubMed ID: 33095968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.
    Andrenyak DM; Moody DE; Slawson MH; O'Leary DS; Haney M
    J Anal Toxicol; 2017 May; 41(4):277-288. PubMed ID: 28069869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hair analysis for delta(9)-THC, delta(9)-THC-COOH, CBN and CBD, by GC/MS-EI. Comparison with GC/MS-NCI for delta(9)-THC-COOH.
    Baptista MJ; Monsanto PV; Pinho Marques EG; Bermejo A; Avila S; Castanheira AM; Margalho C; Barroso M; Vieira DN
    Forensic Sci Int; 2002 Aug; 128(1-2):66-78. PubMed ID: 12208025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromatographic analysis of CBD and THC after their acylation with blockade of compound transformation.
    Typek R; Holowinski P; Dawidowicz AL; Dybowski MP; Rombel M
    Talanta; 2023 Jan; 251():123777. PubMed ID: 36075144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated extraction and LC-MS-MS analysis of 11-nor-9-carboxy-tetrahydrocannabinol isomers and prevalence in authentic urine specimens.
    Karas LK; Patterson C; Fuller ZJ; Karschner EL
    J Anal Toxicol; 2024 May; 48(4):197-203. PubMed ID: 38581658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.